Stock listing
NASDAQ:BBI Brickell Biotech Inc Stock
Follow Brickell Biotech Inc into a list and get an email when it puts out news.
Delisted NASDAQ:BBI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:BBI
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Brickell Biotech Inc on 6ix
- Calls
- 8 calls with a replay · 8 with a transcript · latest Aug 11, 2022
- Decks
- 3 decks · latest Oct 7, 2021
Events
| Call | When | Status |
|---|---|---|
| Brickell Biotech (BBI) Q2 2022 Earnings Call | Thu, Aug 11, 2022 · 4:30 PM ET | Replay |
| Brickell Biotech (BBI) Q1 2022 Earnings Call | Thu, May 12, 2022 · 4:30 PM ET | Replay |
| Brickell Biotech (BBI) Q4 2021 Earnings Call | Tue, Mar 15, 2022 · 8:30 AM ET | Replay |
| Brickell Biotech (BBI) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 4:30 PM ET | Replay |
| Brickell Biotech (BBI) Q2 2021 Earnings Call | Thu, Aug 12, 2021 · 4:30 PM ET | Replay |
| Brickell Biotech (BBI) Q1 2021 Earnings Call | Thu, May 13, 2021 · 4:30 PM ET | Replay |
| Brickell Biotech (BBI) Q4 2020 Earnings Call | Tue, Mar 09, 2021 · 4:30 PM ET | Replay |
| Brickell Biotech (BBI) Q3 2020 Earnings Call | Thu, Nov 12, 2020 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (October 2021) | Technical | 18 slides | Oct 7, 2021 |
| Technical Presentation (April 2021) | Technical | 19 slides | Apr 23, 2021 |
| Vical — Merger or Acquisition (June 2019) | Merger or acquisition | 18 slides | Jun 3, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gary A. Lyons Other companies: Travere Therapeutics, Inc. (Director · Since at least Oct 8, 2014); Neurocrine Biosciences, Inc. (Director · Since at least May 25, 2010); Eledon Pharmaceuticals, Inc. (Director · May 10, 2017 – May 1, 2023 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); NeurogesX Inc (Director · Apr 27, 2011 – Jun 7, 2012 · Past); Rigel Pharmaceuticals, Inc. (Director · May 28, 2010 – May 26, 2023 · Past); Vical Incorporated (Director · May 25, 2010 – May 23, 2018 · Past); Facet Biotech Corp (Director · Apr 20, 2010 – Apr 21, 2010 · Past) | Director · Feb 14, 2020 – May 17, 2022 · Past |
| David R McAvoy Other companies: Teva Pharmaceutical Industries Limited (EVP, Chief Legal Officer · Since at least Mar 4, 2024); Fresh Tracks Therapeutics Inc. (Gen Counsel, CCO, & Secretary · Jan 24, 2023 – Oct 2, 2023 · Past); Endocyte Inc (General Counsel · Nov 8, 2018 – Dec 21, 2018 · Past) | General Counsel and CCO · Aug 31, 2019 – May 5, 2022 · Past |
| Vijay B Samant Other companies: Armata Pharmaceuticals, Inc. (Director · Nov 5, 2015 – Sep 7, 2017 · Past); Raptor Pharmaceutical Corp (Director · Apr 11, 2011 – Apr 7, 2014 · Past); Vical Incorporated (President & CEO, Director · Apr 6, 2007 – Jun 18, 2018 · Past) | Director · Feb 14, 2020 – May 17, 2022 · Past |
| Andrew D Sklawer Other companies: Fresh Tracks Therapeutics Inc. (President and CEO · Jan 24, 2023 – Oct 2, 2023 · Past) | COO and Secretary · Aug 31, 2019 – May 5, 2022 · Past |
| George B Abercrombie Other companies: BioCryst Pharmaceuticals, Inc. (Director · May 29, 2019 – Jun 12, 2024 · Past) | CHIEF EXECUTIVE OFFICER, Director · Aug 31, 2019 – Feb 14, 2020 · Past |
| Reginald L Hardy Other companies: Chemomab Therapeutics Ltd. (Director · Jan 1, 2020 – Jan 1, 2020 · Past) | CHAIRMAN OF THE BOARD, Director · Aug 31, 2019 – May 17, 2022 · Past |
| Jose Breton | Chief Accounting Officer · Aug 31, 2019 – May 5, 2022 · Past |
| Robert Busard Brown | Chief Executive Officer, Director · Aug 31, 2019 – May 5, 2022 · Past |
Log in to ask 6ix AI your own questions about Brickell Biotech Inc.